Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS 15943) Having High Potency at the Human A2B and A3 Receptor Subtypes-Reference-Cited by-同舟云学术

Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS 15943) Having High Potency at the Human A2B and A3 Receptor Subtypes

Published:1998-06-18 Issue:15 Volume:41 Page:2835-2845
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kim Yong-Chul¹,de Zwart Maarten¹,Chang Louis¹,Moro Stefano¹,von Frijtag Drabbe Künzel Jacobien K.¹,Melman Neli¹,IJzerman Ad P.¹,Jacobson Kenneth A.¹

Affiliation:

1. Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0810, and Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, P.O. Box 9502, 2300 RA Leiden, The Netherlands

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm980094b

Reference43 articles.

1. A1-Adenosine receptor antagonists

2. Characterization of adenosine receptors in rat brain by (?)[3H]N6-phenylisopropyladenosine

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and hydrolytic decomposition of 2-hetaryl[1,2,4]triazolo[1,5-c]quinazolines: DFT study;Structural Chemistry;2023-11-08

2. МЕТОДИ СИНТЕЗУ ХІНАЗОЛІНІВ ТА ЇХ КОНДЕНСОВАНИХ ПОХІДНИХ – ПОТЕНЦІЙНИХ ПРОТИЗАПАЛЬНИХ АГЕНТІВ (ОГЛЯД);Journal of Chemistry and Technologies;2023-07-25

3. A3 Adenosine Receptor Ligands: From Discovery to Clinical Trials;Topics in Medicinal Chemistry;2023

4. Fluorescent A2A and A3 adenosine receptor antagonists as flow cytometry probes;Purinergic Signalling;2022-06-10

5. A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases;Current Medicinal Chemistry;2021-11-29